Juno Therapeutics News Timeline

Juno Therapeutics Inc -- USA Stock  

USD 47.41  1.66  3.63%

This is yet another view into Juno Therapeutics filtered headlines to help investors concentrate on Juno Therapeutics Inc noise-free news that matters. Some academic researchers believe in strong correlation between financial news and their impacts to the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Juno Therapeutics headlines in addition to utilizing other more conventional financial analysis modules. Please also check Juno Therapeutics Backtesting and Juno Therapeutics Hype Analysis
news
November 20, 2017
Clovis Oncology, Inc. vs. Juno Therapeutics, Inc. Which Should ... at economicsandmoney.com 
View Story
news
December 13, 2017
Analysts Layout Best- And Worst-Case Scenarios Juno Therapeutics, Inc. JUNO ... at postanalyst.com 
View Story
news
December 13, 2017
Do not Let Stock Prices Fool You NantKwest, Inc. , Frontier Communications ... at postanalyst.com 
View Story
news
December 12, 2017
Wall Street Stock Recommendations DelMar Pharmaceuticals, Inc. DMPI ... at postanalyst.com 
View Story
news
December 11, 2017
VBI Vaccines Inc. Just Recorded A Sigfniciant Decline at weeklyregister.com 
View Story
news
December 13, 2017
TherapeuticsMD, Inc. is at 6.80 per share and Vascular Biogenics Ltd ... at www.stocksgallery.com 
View Story